Fresenius Kabi is recalling one of its injectable drugs because of potential contamination with glass particles. The recall affects four lots of benztropine mesylate, a drug to treat the symptoms of Parkinson’s disease and tremors caused by other medical problems or drugs. In some cases, the glass particles in the vials of the drug have been visible. The warning to customers said that in some cases if the glass particles split into layers, the glass particulate can be too small for the naked eye to see. No adverse events or customer complaints have been reported to date, however if the ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.